PT-141
$49.00
Secure checkout
PT-141 (Bremelanotide) is a synthetic melanocortin receptor agonist derived from the α-MSH peptide family. It has been widely studied for its activity on central nervous system pathways involved in sexual desire, arousal, and behavioral signaling. Unlike agents that act primarily through vascular mechanisms, PT-141 works through neural melanocortin receptors—particularly MC3R and MC4R—making it a unique subject of interest in sexual-function research.
Scientific investigations have explored PT-141’s ability to modulate desire and arousal by activating specific brain pathways that influence motivation, reward, and intimate connection. Research in both men and women has examined its effects on libido, central arousal cues, subjective satisfaction, and sexual responsiveness. Because its mechanism is centrally mediated rather than vascular, PT-141 has also been studied in individuals who do not respond to traditional blood-flow–based therapies.
PT-141 remains a significant focus in neuroendocrine and sexual-function research due to its distinctive mechanism of action and its broad relevance across both male and female sexual-response pathways.
Frequently Asked Questions
Peptides are rarely explained well outside of academic settings. You may already recognize familiar examples like insulin, oxytocin, or collagen. These are all peptides and play important roles in biological systems.
Peptides are short chains of amino acids and are considered the building blocks of many complex biological processes. Thousands of distinct peptide structures have been identified across living organisms, where they participate in signaling pathways, cellular communication, and molecular regulation.
Because of their specificity and versatility, peptides are widely studied in laboratory and research environments to better understand how biological systems adapt, repair, and change over time. Different peptides interact with different cellular targets, making them valuable tools for investigating mechanisms related to metabolism, aging, regeneration, resilience, and cognitive function at a molecular level.
Today, peptides remain an active and rapidly evolving area of scientific research, offering insight into how complex biological processes are initiated, regulated, and optimized.
Peptides should be stored in a refrigerator (2°C to 8°C) after reconstitution. Lyophilized (powdered) peptides should also be kept in a cool, dry place until reconstitution or in a freezer for long term storage.
To preserve the integrity of peptides, proper storage is essential. While some peptides are more susceptible to degradation than others, knowing and implementing the best practices for peptide storage can greatly lengthen their stability.
Once peptides have been received, make sure they are kept cold and away from light. If the peptides will be used immediately, or in the next several days, weeks or months, short-term refrigeration under 4C (39F) is acceptable. Lyophilized peptides are usually stable at room temperatures for several weeks or more, so if they will be utilized within weeks or months room temperature is adequate.
For longer term storage it is preferable to store peptides in a freezer at -80C (-112F). When storing peptides for months or even years, freezing is optimal in order to preserve the peptide’s stability.
Avoid repeated freeze-thaw cycles. This can increase the peptide’s susceptibility to degradation. Also, frost-free freezers should be avoided to store peptides, as temperatures can fluctuate widely during defrosting cycles.
Lyophilization is a freeze-drying process that removes moisture from a compound to improve stability during storage and transport. Many peptides are supplied in lyophilized (powder) form for this reason.
Peptides in dry form are generally more stable than liquid formulations. This allows for longer shelf life prior to preparation and helps preserve integrity during shipping.
AÂ Certificate of Analysis (COA)Â is a quality document that summarizes analytical testing performed on a specific product batch. It helps confirm identity, purity, and consistency. Typically includes:
- Product name
- Peptide sequence or abbreviation
- Batch or Lot Number
- Manufacturing date
- Test or report date
Identity testing (MS)Â confirms that the compound analyzed matches the intended molecular structure.
Purity (HPLC)Â refers to how much of the sample is the intended compound versus related fragments or residuals.
Sterility and endotoxin testing are quality and contamination-screening tools.
Sterility testing is performed to assess whether a sample contains viable microorganisms (such as bacteria or fungi) under specific test conditions. It is a growth-based test, meaning samples are incubated and observed over time.
Endotoxin testing screens for lipopolysaccharides (LPS) — components of the outer membrane of certain bacteria. Sterility and endotoxin testing may not be required or meaningful for every peptide due to:
- Synthetic manufacturing processes that do not involve biological growth media
- Short peptide sequences that undergo cleavage, purification, and solvent exposure
- Lyophilization, which limits microbial viability
- Batch handling and packaging format
While sterility and endotoxin testing are not required for all peptides, Soma goes above and beyond standard industry practices by offering sterility and endotoxin reports on products and upon request. This additional testing reflects our commitment to transparency, quality oversight, and providing partners with robust batch-level documentation to support their internal review and compliance processes.
We’re happy to help answer questions. Email us at care@somapeptides.com. Our support team is available M-F 9:00 AM – 4:00 PM Pacific.
Call Us Directly
Customers: +1 888-818-6543
Send a Message
Customers: care@somapeptides.com
Help Center
Phone: +1 888-818-6543
Email: care@somapeptides.com
Purity (HPLC)
PassedAssessed via reverse-phase High-Performance Liquid Chromatography (HPLC) with UV detection to quantify the target compound and detect impurities. High purity reduces the presence of unintended constituents that may affect analytical outcomes.
Identity (USP <621>)
PassedConfirms the molecular identity of the compound by chromatographic comparison against qualified reference standards per USP <621>. Identity verification is foundational to ensure the material being analyzed is correct and properly characterized.
Net Content (USP <41>)
PassedVerifies that each vial meets its labeled quantity within acceptable variance, measured gravimetrically on a calibrated analytical balance per USP <41>. Accurate net content supports consistency across batches and reliability in downstream applications.
Multi-Vial Variance (USP <905>)
PassedMultiple vials from the same lot are tested individually for purity, identity, and net content to confirm uniformity across the batch, following the uniformity of dosage units principles of USP <905>. This helps ensure consistent composition and performance vial to vial.
Endotoxins (USP <85>)
PassedMeasures bacterial endotoxin levels using validated LAL methods per USP <85>. Endotoxin control is critical for minimizing biological interference and maintaining integrity in sensitive analytical systems.
Microbial (USP <61>/<62>)
PassedAssesses total aerobic and yeast/mold counts per USP <61> and screens for specified organisms per USP <62> to confirm compliance with microbiological quality standards. This helps ensure controlled, clean finished material.
Heavy Metals (ICP-MS, USP <233>)
PassedScreens for elemental impurities such as lead, arsenic, cadmium, and mercury by ICP-MS per USP <233>, against the elemental impurity limits of USP <232>. Monitoring trace metals supports material purity and overall quality assurance.
Residual Solvents (USP <467>)
PassedScreens for trace solvents left behind by synthesis, purification, and drying — such as acetonitrile, methanol, dichloromethane, ethanol, ethyl acetate, and other Class 1, 2, and 3 solvents. These are tested because residual solvents carry toxicity and impurity risk at low levels, so each lot is confirmed to sit within USP <467> safety limits.
Adulterant Testing (USP <2251>)
PassedScreened per USP <2251> (Screening for Undeclared Drugs and Drug Analogues) for undeclared drugs and drug analogues, confirming the material is free of illicit contaminants.
